BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue20,776,00019,427,00016,560,000
Cost of Revenue6,066,0004,946,0003,909,000
Gross Profit14,710,00014,481,00012,651,000
Operating Expenses
Research Development6,411,0004,940,0005,920,000
Selling General and Administrative4,687,0004,911,0004,841,000
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss3,612,0004,630,0001,890,000
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes5,131,0005,915,0002,077,000
Interest Expense---
Income Before Tax5,131,0005,915,0002,077,000
Income Tax Expense4,156,0001,408,000446,000
Minority Interest106,000170,000158,000
Net Income From Continuing Ops1,007,0004,457,0001,565,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income1,007,0004,457,0001,565,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares1,007,0004,457,0001,565,000